Why Your Doctor Keeps Telling You Your Labs Are Normal When You Feel Terrible
By Glow Health | Menopause & Sexual Health Specialists
You have been telling your clinician for months, maybe years, that something is wrong. You are exhausted in a way that sleep does not fix. Your mood is unpredictable. Your memory is not what it was. Your periods have changed. You feel like a different person. And every time you bring it up, you are told the same thing: your labs look normal. Come back in a year.
You leave the appointment feeling dismissed, confused, and vaguely like you might be making it up. You are not making it up. And in many cases, the labs genuinely do look normal, not because nothing is wrong, but because the wrong labs are being ordered, or the right labs are being interpreted without enough clinical context.
Understanding why this happens is not just validating. It can help you ask better questions and advocate for more complete care.
The problem with standard lab panels
Most routine bloodwork is designed to screen for established disease, not to identify the early hormonal and metabolic shifts that characterize the menopausal transition. The tests that get ordered are often the same ones ordered for a 30-year-old with no symptoms, and they are interpreted against reference ranges that were not designed with perimenopausal women in mind.
Here is where standard panels frequently fall short.
Hormonal testing during perimenopause is notoriously unreliable
The most common hormonal tests used to assess menopausal status are FSH (follicle-stimulating hormone) and estradiol. Both are problematic during perimenopause.
FSH and estradiol fluctuate dramatically during the perimenopausal transition, sometimes day to day and even hour to hour. A single blood draw can look entirely normal on a Tuesday and perimenopausal on a Friday. Many women are told their hormones are fine based on one result drawn at one point in time, without any appreciation for how much these levels can vary.
This is not a subtle limitation. The SWAN (Study of Women's Health Across the Nation) study documented this variability extensively. A normal FSH does not rule out perimenopause. It rules out the possibility that your FSH was elevated on the day your blood was drawn, which is a much more limited conclusion than most women are led to believe.
The diagnosis of perimenopause is primarily clinical, meaning it is based on symptoms and menstrual history, not on a lab result. A clinician who relies solely on bloodwork to determine whether a woman is perimenopausal will miss a significant proportion of women who are.
Iron deficiency without anemia
A standard complete blood count (CBC) will flag anemia when hemoglobin and hematocrit fall below normal. But iron deficiency can cause significant symptoms, including profound fatigue, brain fog, poor concentration, hair loss, and reduced exercise tolerance, well before anemia develops.
The marker that captures early iron deficiency is ferritin, the protein that stores iron in the body. Ferritin can be low even when hemoglobin and hematocrit are entirely normal, and it is frequently not included in routine bloodwork.
To make this more complicated, ferritin is also an acute phase reactant, meaning it rises with inflammation. A woman with chronic low-grade inflammation, which becomes more common during the menopausal transition, may have a ferritin level that appears normal or even elevated while her actual iron stores are depleted. Looking at ferritin alongside other iron markers, including serum iron, transferrin saturation, and TIBC, gives a more complete picture.
Heavy or irregular periods during perimenopause, which are extremely common, can also accelerate iron loss significantly. Many women in this group are walking around with suboptimal iron stores that are contributing directly to their fatigue and cognitive symptoms, without anyone having checked.
Insulin resistance before diabetes
A standard metabolic panel will typically include fasting glucose and, sometimes, HbA1c. These are reasonable screening tools, but they are late-stage markers. By the time fasting glucose or HbA1c are abnormal, insulin resistance has often been developing for years.
Fasting insulin is a far more sensitive early marker of insulin resistance and metabolic dysfunction. It is almost never included in routine bloodwork despite the fact that elevated fasting insulin, even in the presence of normal glucose and HbA1c, is associated with weight gain, fatigue, brain fog, difficulty losing weight, increased cardiovascular risk, and inflammation. All of these are symptoms that perimenopausal women frequently report, and all of them can be driven by insulin resistance that standard labs will completely miss.
The HOMA-IR calculation, which uses fasting insulin and fasting glucose together to estimate insulin resistance, provides even more useful information. A woman can have a perfectly normal fasting glucose and a perfectly normal HbA1c while her HOMA-IR reveals significant insulin resistance that is driving her symptoms and her metabolic trajectory.
As estrogen declines during menopause, insulin sensitivity decreases. This is a well-documented hormonal effect, and it means that perimenopausal and postmenopausal women are at particular risk for developing insulin resistance that goes undetected on standard panels.
Cardiovascular risk beyond the basic lipid panel
A standard lipid panel measures total cholesterol, LDL, HDL, and triglycerides. These are useful but incomplete. Several additional markers provide a significantly more detailed picture of cardiovascular risk, and they are rarely ordered in routine care.
Apolipoprotein B (ApoB) measures the number of atherogenic particles in the blood, which is a more direct indicator of cardiovascular risk than LDL cholesterol alone. Two women can have identical LDL levels but very different ApoB levels, and the woman with higher ApoB has more particles capable of causing arterial damage. A lipid panel that looks reassuring can coexist with an ApoB level that signals meaningful cardiovascular risk.
Lipoprotein(a), or Lp(a), is a genetically determined lipoprotein that is an independent risk factor for cardiovascular disease and is not modified by diet, exercise, or standard lipid-lowering medications. It is not included in routine lipid panels and is unknown to most people until they specifically request it. Elevated Lp(a) is common, affects approximately 20% of the population, and significantly increases risk for heart attack and stroke. Every woman should know her Lp(a) level, ideally early in life, because it informs long-term risk management.We used to believe this was a fixed number, but newer evidence shows this number may change in perimenopause.
High-sensitivity C-reactive protein (hsCRP) is a marker of systemic inflammation and an independent predictor of cardiovascular risk. As estrogen declines during menopause, inflammatory markers tend to rise. An hsCRP that is elevated, even modestly, tells a different story about cardiovascular risk than a standard lipid panel alone and may prompt earlier or more aggressive intervention.
The menopausal transition is a time when cardiovascular risk shifts meaningfully, as discussed in our post on menopause and your heart. Standard lipid panels ordered during this period without these additional markers leave a significant part of the picture unseen.
Thyroid function: TSH alone is not always enough
Thyroid disease becomes more common in midlife and produces symptoms that overlap almost entirely with menopause: fatigue, brain fog, weight changes, mood disruption, sleep problems, and changes in hair and skin. Most clinicians screen with TSH alone, which is a reasonable starting point but has limitations.
TSH can be within the normal reference range while free T3 and free T4 are suboptimal. Some women feel significantly better when their thyroid hormones are optimized within the range, not just technically normal. Thyroid antibodies, particularly anti-TPO antibodies, can identify autoimmune thyroid disease (Hashimoto's thyroiditis) before TSH becomes abnormal, which can explain symptoms and inform long-term monitoring even when treatment is not yet indicated.
A woman who is told her thyroid is fine based on TSH alone may still be experiencing meaningful thyroid dysfunction that is contributing to her symptoms.
Vitamin D deficiency
Vitamin D deficiency is extremely common in midlife women and is associated with fatigue, low mood, muscle weakness, bone loss, and immune dysfunction. It is frequently not included in routine bloodwork, and when it is tested, levels that fall within the broad laboratory normal range may still be suboptimal for health.
Most experts in menopause medicine aim for 25-hydroxyvitamin D levels of 40 to 60 ng/mL for optimal bone and overall health. A level of 21 ng/mL technically falls within the normal range on most lab reports but represents significant insufficiency in practice.
What you can do
If you have been told your labs are normal and you still feel terrible, consider asking your clinician specifically about the following:
Ferritin (not just CBC) to assess iron stores
Fasting insulin and HOMA-IR to screen for early insulin resistance
ApoB and Lp(a) for a more complete cardiovascular risk picture
hsCRP for inflammatory burden
Free T3, free T4, and thyroid antibodies alongside TSH
25-hydroxyvitamin D level
You may need to ask directly for these tests rather than waiting for them to be offered. Many are not part of standard panels but are available at most labs and are covered by most insurance plans, though coverage varies.
It is also worth knowing that a thorough clinical assessment of your symptoms, your menstrual history, and your overall picture is often more informative than any individual lab result. If a clinician is relying on standard bloodwork alone to tell you whether something hormonal is happening, they are missing significant diagnostic territory.
How Glow Health can help
At Glow Health, we take a comprehensive approach to evaluation that goes beyond the standard lab panel. We look at the markers that are most relevant to the menopausal transition, we interpret results in the context of your symptoms and your clinical picture, and we do not dismiss what you are experiencing because a basic blood test came back within range.
If you have been told your labs are normal and you know something is wrong, that is a conversation worth having.
Keywords: labs normal but feel terrible menopause, perimenopause normal labs, menopause blood tests, fasting insulin perimenopause, ferritin menopause fatigue, ApoB menopause, Lp(a) women, menopause bloodwork
This post is for informational purposes only and does not constitute medical advice. Please consult a qualified healthcare clinician for personalized guidance.
